Home/Cuorips/Yoshiki Sawa
YS

Yoshiki Sawa

Director of the Board and CTO

Cuorips

Therapeutic Areas

Cuorips Pipeline

DrugIndicationPhase
iPSC-derived Cardiomyocyte PatchesSevere Heart FailureConditionally Approved